MORGAN STANLEY PLC/CALL/CVS HEALTH/89/0.1/20.12.24 Stock

Warrant

DE000MB33T78

Real-time Bid/Ask 11:17:23 2024-07-11 EDT
0.042 EUR / 0.044 EUR +4.88% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/89/0.1/20.12.24
1 month-10.87%
3 months-67.20%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 0.042 +2.44%
24-07-10 0.041 +2.50%
24-07-09 0.04 0.00%
24-07-08 0.04 +5.26%
24-07-05 0.038 +8.57%

Delayed Quote Börse Stuttgart

Last update July 11, 2024 at 09:51 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB33T7
ISINDE000MB33T78
Date issued 2023-02-01
Strike 89 $
Maturity 2024-12-20 (162 Days)
Parity 10 : 1
Emission price 1.3
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.37
Lowest since issue 0.021
Delta0.07x
Omega 9.158
Premium54.46x
Gearing126.77x
Moneyness 0.6507
Difference Strike 30.88 $
Difference Strike %+34.70%
Spread 0.002
Spread %4.65%
Theoretical value 0.0430
Implied Volatility 40.58 %
Total Loss Probability 95.65 %
Intrinsic value 0.000000
Present value 0.0430
Break even 89.47 €
Theta-0x
Vega0x
Rho0x

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
57.53 USD
Average target price
69.1 USD
Spread / Average Target
+20.10%
Consensus